Correlation Between HLS Therapeutics and BC Bud
Can any of the company-specific risk be diversified away by investing in both HLS Therapeutics and BC Bud at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining HLS Therapeutics and BC Bud into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between HLS Therapeutics and The BC Bud, you can compare the effects of market volatilities on HLS Therapeutics and BC Bud and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in HLS Therapeutics with a short position of BC Bud. Check out your portfolio center. Please also check ongoing floating volatility patterns of HLS Therapeutics and BC Bud.
Diversification Opportunities for HLS Therapeutics and BC Bud
-0.47 | Correlation Coefficient |
Very good diversification
The 3 months correlation between HLS and BCBCF is -0.47. Overlapping area represents the amount of risk that can be diversified away by holding HLS Therapeutics and The BC Bud in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on BC Bud and HLS Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on HLS Therapeutics are associated (or correlated) with BC Bud. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of BC Bud has no effect on the direction of HLS Therapeutics i.e., HLS Therapeutics and BC Bud go up and down completely randomly.
Pair Corralation between HLS Therapeutics and BC Bud
Assuming the 90 days horizon HLS Therapeutics is expected to generate 0.28 times more return on investment than BC Bud. However, HLS Therapeutics is 3.51 times less risky than BC Bud. It trades about 0.1 of its potential returns per unit of risk. The BC Bud is currently generating about -0.01 per unit of risk. If you would invest 269.00 in HLS Therapeutics on December 27, 2024 and sell it today you would earn a total of 51.00 from holding HLS Therapeutics or generate 18.96% return on investment over 90 days.
Time Period | 3 Months [change] |
Direction | Moves Against |
Strength | Very Weak |
Accuracy | 93.44% |
Values | Daily Returns |
HLS Therapeutics vs. The BC Bud
Performance |
Timeline |
HLS Therapeutics |
BC Bud |
HLS Therapeutics and BC Bud Volatility Contrast
Predicted Return Density |
Returns |
Pair Trading with HLS Therapeutics and BC Bud
The main advantage of trading using opposite HLS Therapeutics and BC Bud positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if HLS Therapeutics position performs unexpectedly, BC Bud can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in BC Bud will offset losses from the drop in BC Bud's long position.HLS Therapeutics vs. Aion Therapeutic | HLS Therapeutics vs. Cannara Biotech | HLS Therapeutics vs. Knight Therapeutics | HLS Therapeutics vs. Canntab Therapeutics Limited |
BC Bud vs. Amexdrug | BC Bud vs. Crescita Therapeutics | BC Bud vs. Aion Therapeutic | BC Bud vs. Alterola Biotech |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Manager module to state of the art Portfolio Manager to monitor and improve performance of your invested capital.
Other Complementary Tools
Equity Search Search for actively traded equities including funds and ETFs from over 30 global markets | |
Fundamental Analysis View fundamental data based on most recent published financial statements | |
Share Portfolio Track or share privately all of your investments from the convenience of any device | |
Portfolio Comparator Compare the composition, asset allocations and performance of any two portfolios in your account | |
Competition Analyzer Analyze and compare many basic indicators for a group of related or unrelated entities |